Variables | SD(n = 28) | NSD(n = 30) | HC(n = 30) | T/F/χ | p |
---|---|---|---|---|---|
Sex(M/F) | 13/15 | 14/16 | 17/13 | 0.810a | 0.667a |
Age, y | 37.21 ± 7.16 | 34.10 ± 9.91 | 35.83 ± 8.15 | 0.256b | 0.775b |
Education, y | 13.36 ± 3.83 | 14.77 ± 2.94 | 14.23 ± 2.47 | 1.158b | 0.228b |
Duration of illness, mo | 30.64 ± 47.03 | 68.07 ± 86.23 | – | -2.070c | 0.044c |
Age at onset, y | 34.54 ± 8.52 | 28.33 ± 8.54 | – | 2.020c | 0.048c |
Depression, No. of episodes | 1.64 ± 1.25 | 2.37 ± 1.71 | – | -1.826c | 0.073c |
HAMD-17 Total score | 23.61 ± 4.13 | 22.80 ± 4.98 | – | 0.669c | 0.506c |
Anxiety | 6.71 ± 2.12 | 5.37 ± 2.22 | – | 2.263c | 0.022c |
Cognitive disturbance | 3.00 ± 1.72 | 4.00 ± 2.23 | – | -1.903c | 0.062c |
Retardation | 7.75 ± 1.71 | 8.23 ± 1.87 | – | -1.024c | 0.310c |
Sleep disturbance | 4.32 ± 1.66 | 4.23 ± 2.11 | – | 0.176c | 0.861c |
Weight loss | 0.75 ± 0.97 | 0.77 ± 0.86 | – | -0.070c | 0.945c |
Antidepressants | |||||
 SSRI | 9 | 14 |  |  |  |
 SNRI | 7 | 8 |  |  |  |
 NaSSA | 1 | 3 |  |  |  |
 Treatment-naive | 11 | 5 |  |  |  |